Bacteremia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 3 I, 1996, Pages 617-624

  Brun Buisson, Christian ^a   Doyon, Françoise ^b   Carlet, Jean ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTEREMIA; COAGULASE NEGATIVE STAPHYLOCOCCUS; GRAM NEGATIVE BACTERIUM; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEPSIS; SHOCK; URINARY TRACT INFECTION;

EID: 0029793532     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.3.8810595     Document Type: Article

References (37)

1. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. H. Schein, W. J. Sibbald, and the ACCP/SCCM Consensus Conference Committee. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1656-1662.
2. Knaus, W. A., X. Sun, P. O. Nystrom, and D. P. Wagner. 1992. Evaluation of definitions for sepsis. Chest 101:1656-1662.
3. Ziegler, E. J., C. J. Fisher, C. L. Sprung, R. C. Straube, J. C. Sadoff, G. E. Foulke, C. H. Wortel, M. P. Fink, R. P. Dellinger, N. N. Teng, I. E. Allen, H. J. Berger, G. L. Knatterud, A. F. LoBuglio, C. R. Smith, and the HA-1A Sepsis Study Group. 1991. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. N. Engl. J. Med. 324:429-436.
4. Greenman, R. L., R. M. H. Schein, M. A. Martin, R. P. Wenzel, N. R. McIntyre, G. Emmanuel, H. Chmel, R. B. Kohler, M. McCarthy, J. Plouffe, J. A. Russell, and the Xoma Sepsis Study Group. 1991. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. J.A.M.A. 266:1097-1102.
5. Brun-Buisson, C., A. Lepoutre, F. Blot, and the National Committee for the evaluation of Centoxin (HA-1A). 1994. The French national registry of HA-1A in septic shock. A cohort study of 600 patients. Arch. Intern. Med. 154:2484-2491.
6. Rangel-Frausto, S., D. Pittet, M. Costignan, T. Hwang, C. S. Davis, and R. P. Wenzel. 1995. The natural history of the systemic inflammatory response syndrome. J.A.M.A. 273:117-123.
7. Brun-Buisson, C., F. Doyon, J. Carlet, P. Dellamonica, F. Gouin, A. Lepoutre, J. C. Mercier, G. Offenstadt, and B. Régnier. 1995. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. J.A.M.A. 274:968-974.
8. Wenzel, R. P. 1992. Anti-endotoxin monoclonal antibodies. A second look. N. Engl. J. Med. 326:1151-1152.
9. Centers for Disease Control. 1990. Increase in national hospital discharge survey rales for septicemia-United States, 1979-1987. M.M.W.R. 39: 31-34.
10. Fischer, C. J., J. Dhainaut, S. M. Opal, J. P. Pribble, R. A. Balk, G. J. Slotman, T. J. Iberti, E. C. Rackow, M. J. Shapiro, R. L. Greenman, H. D. Reines, M. P. Shelly, B. W. Thompson, J. F. LaBrecque, M. A. Catalano, W. A. Knaus, J. C. Sadoff, and The Phase III rhIL-1ra Sepsis Study Group. 1994. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial. J.A.M.A. 271:1836-1843.
11. Warren, H. S., R. L. Danner, and R. S. Munford. 1992. Anti-endotoxin monoclonal antibodies. N. Engl. J. Med. 326:1153-1156.
12. McCabe, W. A., and G. G. Jackson. 1962. Gram-negative bacteremia. I. Etiology and ecology. Arch. Intern. Med. 110:847-855.
13. Dean, A. D., J. A. Dean, J. H. Burton, and R. C. Dicker. 1993. Epi Info: a word processing, database, and statistics program for epidemiology. Centers for Disease Control, Atlanta, GA.
14. Breslow, N. F., and N. E. Day. 1980. The analysis of case-control studies. In Statistical Methods in Cancer Research. International Agency for Research on Cancer, Lyon, France.
15. Kaplan, E. L., and P. Meier. 1958. Non parametric estimation from incomplete information. J. Am. Stat. Assoc. 53:457-481.
16. Cox, D. R. 1972. Regression models and life table (with discussion). J. R. Stat. Soc. 34:248-275.
17. Pittet, D., S. Rangel-Frausto, D. Tarara, M. Costignan, L. Rempe, P. Jebson, and R. P. Wenzel. 1995. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical 1CU patients. Intensive Care Med. 21: 302-309.
18. Smail, N., A. Messiah, A. Edouard, A. Descorps-Declère, J. Duranteau, B. Vigué, O. Mimoz, and K. Samii. 1995. Role of systemic inflammatory response syndrome and infection in the occurrence of early multiple organ dysfunction syndrome following severe trauma. Intensive Care Med. 21:813-816.
19. Casey, L. C., R. A. Balk, and R. C. Bone. 1993. Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119:771-778.
20. Pittet, D., and R. P. Wenzel. 1995. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch. Intern. Med. 155:1177-1184.
21. Ispahani, P., N. J. Pearson, and D. Greenwood. 1987. An analysis of community-acquired and hospital-acquired bacteremia in a large teaching hospital in the United Kingdom. Q. J. Med. 63:427-440.
22. Roberts, F. J., I. W. Geere, and A. Coldman. 1991. A three-year study of positive blood cultures, with emphasis on prognosis. Rev. Infect. Dis. 13:34-46.
23. Weinstein, M. P., R. B. Reller, J. R. Murphy, and K. A. Lichtenstein. 1983. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations with special reference to factors influencing prognosis. Rev. Infect. Dis. 5:54-70.
24. Geerdes, H. F., D. Ziegler, H. Lode, M. Hund, A. Loehr, W. Fangman, and J. Wagner. 1992. Septicemia in 980 patients at a university hospital in Berlin: prospective study during 4 selected years between 1979 and 1989. Clin. Infect. Dis. 15:991-1002.
25. Eykin, S. J., W. R. Grandsen, and I. Phillips. 1990. The causative organisms of septicemia and their epidemiology. J. Antimicrob. Chemother. 25:41-58.
26. Martin, M. A., M. A. Pfaller, and R. P. Wenzel. 1989. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann. Intern. Med. 110:9-16.
27. Bryan, C. S., K. L. Reynolds, and E. R. Brenner. 1983. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev. Infect. Dis. 5:629-638.
28. Uzun, O., H. E. Akalin, M. Hayran, and S. Unal. 1992. Factors influencing prognosis in bacteremia due to gram-negative organisms: evaluation of 448 episodes in a Turkish university hospital. Clin. Infect. Dis. 15:866-873.
29. Aubé, H., C. Milan, and B. Blettery. 1992. Risk factors for septic shock in the early management of bacteremia. Am. J. Med. 93:283-288.
30. Grandsen, W. R., S. J. Eykin, I. Phillips, and B. Rowe. 1990. Bacteremia due to E. Coli: a study of 861 episodes. Rev. Infect. Dis. 12: 1008-1018.
31. Kreger, B. E., D. E. Craven, and W. A. McCabe. 1980. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am. J. Med. 68:344-355.
32. Miller, P. J., and R. P. Wenzel. 1987. Etiologic organisms as independent predictors of death in nosocomial bloodstream infection. J. Infect. Dis. 156:471-477.
33. Pittet, D., D. Tarara, and R. P. Wenzel. 1994. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. J.A.M.A. 271:1598-1601.
34. McCue, J. D. 1985. Improved mortality in gram-negative bacillary bacteremia. Arch. Intern. Med. 145:1212-1216.
35. McGowan, J. E., M. W. Barnes, and M. Finland. 1975. Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935-1972) with special reference to hospital-acquired cases. J. Infect. Dis. 132:316-335.
36. Tomasz, A. 1994. Multiple antibiotic-resistant bacteria. A report from the Rockefeller University workshop. N. Engl. J. Med. 330:1247-1251.
37. Bone, R. C., C. J. Fischer, T. P. Clemmer, G. J. Slotman, C. A. Metz, and R. A. Balk. 1989. Sepsis syndrome: a valid clinical entity. Crit. Care Med. 17:389-393.